News & Media

Recent updates from Arcutis.

September 20, 2022 Featured

Journal of the American Medical Association Publishes Roflumilast Cream 0.3% Results from Pivotal DERMIS-1 and -2 Phase 3 Trials in Plaque Psoriasis

July 29, 2022 Featured

FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older

September 26, 2022

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

September 9, 2022

New Data from Arcutis’ STRATUM Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Seborrheic Dermatitis Presented at European Academy of Dermatology and Venereology (EADV) Congress

September 7, 2022

Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.

September 6, 2022

New Data from Arcutis’ Topical Roflumilast Clinical Program Presented at the European Academy of Dermatology and Venereology (EADV) Congress

September 2, 2022

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 2, 2022

Arcutis Announces Appointment of Neha Krishnamohan to Board of Directors

September 1, 2022

Arcutis to Present at Upcoming Investor Conference

August 30, 2022

New Campaign from Arcutis Aims to Expose the Impact of Psoriasis on Physical, Mental, and Emotional Wellbeing

August 23, 2022

Arcutis Completes Enrollment in INTEGUMENT-2 Pivotal Phase 3 Trial of Roﬂumilast Cream in Atopic Dermatitis

August 22, 2022

Arcutis Announces Arcutis Cares™ Patient Assistance Program (PAP) For Financially Qualified Uninsured and Underinsured Patients

August 10, 2022

Arcutis Launches ZORYVE™ (Roflumilast) Cream 0.3% in the United States for Treatment of Plaque Psoriasis in Individuals Age 12 and Older

Media Resources

Roflumilast Foam: Phase 2 Trial for the Treatment of Seborrheic Dermatitis

The Impact of Seborrheic Dermatitis

New England Journal of Medicine, Infographic / Backgrounder, July 2020

Media Contact

Amanda Shelton

805.418.5006
media@arcutis.com

Meaningful innovation at a glance.

Download our corporate fact sheet.

Download